4CPS-152 Eculizumab for dense deposit disease: increased dosage without response: a case report

BACKGROUND: Dense deposit disease (DDD) is a rare glomerulonephritis caused by uncontrolled stimulation of the alternative complement pathway. Allograft survival after kidney transplantation is significantly reduced by the high rate of disease recurrence. No therapeutic interventions have consistent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Principais autores: Ferreras, A Rodríguez, López, E Lázaro, García, I Zapico, Fernández, C Carriles, Blanc, R Menárguez, Martínez, A Arias, Tamames, B Zárate, López, A Pieras, Roces, L Velasco, Lozano-Blázquez, A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535363/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados